Long-term mortality in childhood-onset epilepsy

Matti Sillanpää1, Shlomo Shinnar

  • 1Department of Pediatric Neurology, University of Turku and Turku University Hospital, Turku, Finland.

Insights

Children with epilepsy face a significantly higher risk of death, particularly epilepsy-related fatalities like sudden unexplained death. This risk is amplified in those not in remission, underscoring the need for ongoing management.

Area of Science:

  • Neurology
  • Pediatrics
  • Epidemiology

Background:

  • Limited data exists on long-term mortality in well-characterized pediatric epilepsy cohorts.
  • This study investigates long-term mortality in a Finnish cohort diagnosed with epilepsy in childhood.

Purpose of the Study:

  • To assess long-term mortality in a population-based cohort of children with epilepsy.
  • To identify risk factors associated with increased mortality, including epilepsy-related deaths and sudden unexplained death.

Main Methods:

  • A population-based cohort of 245 children diagnosed with epilepsy in 1964 was prospectively followed for 40 years.
  • Seizure outcomes and mortality rates were assessed, with a high autopsy rate facilitating specific diagnoses.
  • Rates of sudden, unexplained death were specifically estimated.

Main Results:

  • Overall mortality was 24% (60 deaths), three times higher than the general population.
  • Mortality was significantly higher in subjects not in 5-year terminal remission (48%) and those with remote symptomatic epilepsy (37%).
  • Epilepsy-related deaths accounted for 55% of all deaths, including sudden unexplained death in 18 subjects (30%).

Conclusions:

  • Childhood-onset epilepsy is associated with a substantial risk of epilepsy-related mortality, including sudden unexplained death.
  • The risk of death is particularly elevated in children with epilepsy who are not in remission.
  • These findings highlight the critical need for vigilant monitoring and management of childhood epilepsy to mitigate mortality risks.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
414
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
43
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
54